ArticleProceedings of the National Academy of Sciences of the United States of America2014

Molecular dynamics reveal BCR-ABL1 polymutants as a unique mechanism of resistance to PAN-BCR-ABL1 kinase inhibitor therapy.

Don L Gibbons et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.